Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Aurora, CO
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Atlanta, GA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Chicago, IL
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Iowa City, IA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Baltimore, MD
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Boston, MA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Minneapolis, MN
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
St. Louis, MO
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Chapel Hill, NC
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Cincinnati, OH
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Cleveland, OH
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Columbus, OH
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Philadelphia, PA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Pittsburgh, PA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Seattle, WA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
mi
from
Brussels,
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Investigational Site
mi
from
Brussels,
Click here to add this to my saved trials
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Status: Enrolling
Updated:  8/4/2015
mi
from
Norfolk, VA
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Status: Enrolling
Updated: 8/4/2015
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Click here to add this to my saved trials
Effect of CPAP on Postoperative Delirium
The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  8/4/2015
mi
from
Durham, NC
Effect of CPAP on Postoperative Delirium
The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 8/4/2015
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
mi
from
Denver, CO
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Denver Health Medical Centre
mi
from
Denver, CO
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
mi
from
Orlando, FL
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Orlando Regional Medical Centre
mi
from
Orlando, FL
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
mi
from
Ann Arbor, MI
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
mi
from
Greenville, NC
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
mi
from
Philadelphia, PA
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Hospital of the University ofPennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
mi
from
Dallas, TX
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Parkland Memorial Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
mi
from
Houston, TX
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
University of Texas HSC
mi
from
Houston, TX
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
mi
from
Temple, TX
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Texas A&M HSC College of Medicine, Scott & White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
mi
from
Calgary,
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Peter Lougheed Centre/Foothills Medical Centre
mi
from
Calgary,
Click here to add this to my saved trials
Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants
Respiratory Severity and Caloric Consumption on NAVA: Randomized Crossover Trial of NAVA and SIMV
Status: Enrolling
Updated:  8/5/2015
mi
from
Kansas City, MO
Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants
Respiratory Severity and Caloric Consumption on NAVA: Randomized Crossover Trial of NAVA and SIMV
Status: Enrolling
Updated: 8/5/2015
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Birmingham, AL
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
UAB Lung Health Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Torrance, CA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Los Angeles Biomedical Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Kissimmee, FL
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Pulmonary Disease Specialist/PDS Research
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Miami, FL
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Well Pharma Medical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Winter Park, FL
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Florida Premier Research Institute
mi
from
Winter Park, FL
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Austell, GA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Georgia Clinical Research
mi
from
Austell, GA
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Peoria, IL
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Illinios Lung Institute
mi
from
Peoria, IL
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Louisville, KY
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
University of Louisville, Pulmonary Division
mi
from
Louisville, KY
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Omaha, NE
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Philadelphia, PA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Spartanburg, SC
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Spartanburg Medical Research
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Houston, TX
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Texas Institute of Chest and Sleep Disorders, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
San Antonio, TX
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Diagnostics Research Group
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Richmond, VA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Pulmonary Associates of Richmond, Inc
mi
from
Richmond, VA
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
mi
from
Tacoma, WA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Multicare Pulmonary Specialist
mi
from
Tacoma, WA
Click here to add this to my saved trials
Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis
Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis
Status: Enrolling
Updated:  8/7/2015
mi
from
Little Rock, AR
Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis
Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis
Status: Enrolling
Updated: 8/7/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
mi
from
Lincoln, NE
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
BryanLGH Heart Institute
mi
from
Lincoln, NE
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
mi
from
Columbus, OH
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
mi
from
Lancaster, PA
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Lancaster Heart and Stroke Foundation
mi
from
Lancaster, PA
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
mi
from
Nashville, TN
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
St. Thomas Heart
mi
from
Nashville, TN
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
mi
from
Norfolk, VA
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
mi
from
Bad Oeynhausen,
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Heart and Diabetes Center
mi
from
Bad Oeynhausen,
Click here to add this to my saved trials